Secondary Logo

Journal Logo

July 2010 - Volume 25 - Issue 4
pp: 189-245

Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression

Thase, Michael E.; Nierenberg, Andrew A.; Vrijland, Peter; More

International Clinical Psychopharmacology. 25(4):189-198, July 2010.

Better tolerability of St. John's wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depression

Kasper, Siegfried; Gastpar, Markus; Möller, Hans-Juergen; More

International Clinical Psychopharmacology. 25(4):204-213, July 2010.

Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome

Farabaugh, Amy H.; Bitran, Stella; Witte, Janet; More

International Clinical Psychopharmacology. 25(4):214-217, July 2010.

The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case–control association study

Kocabas, Neslihan Aygun; Faghel, Carole; Barreto, Mara; More

International Clinical Psychopharmacology. 25(4):218-227, July 2010.

Increase in brain-derived neurotrophic factor in first episode psychotic patients after treatment with atypical antipsychotics

González-Pinto, Ana; Mosquera, Fernando; Palomino, Aitor; More

International Clinical Psychopharmacology. 25(4):241-245, July 2010.


5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder

Noro, Magali; Antonijevic, Irina; Forray, Carlos; More

International Clinical Psychopharmacology. 25(4):228-231, July 2010.